PLUS1
0.91
-0.0098 (-1.07%)
-0.0098 (-1.07%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aytu BioScience Inc | AYTU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0098 | -1.07% | 0.91 | 08:58:03 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.9198 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.9063 | 0.91 | 0.0037 | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 38 | 21,999 | 2,305,469 | 0.3352 - 2.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:58:03 | formt | 300 | $ 0.91 | USD |
Aytu BioScience Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 116.43M | 127.93M | 125.43M | $ 27.63M | $ -9.00M | -0.32 | -23.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aytu BioScience News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/12/2020 | 16:33 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/12/2020 | 16:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/06/2020 | 16:14 | Edgar (US Regulatory) | Annual Report (10-k) |
| 10/06/2020 | 16:10 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/28/2020 | 17:05 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt.. |
| 8/17/2020 | 12:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/29/2020 | 08:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AYTU Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.923 | 0.9435 | 0.8601 | 0.8962532 | 2,347,213 | -0.013 | -1.41% |
| 1 Month | 0.93 | 1.05 | 0.8601 | 0.9614459 | 2,482,879 | -0.02 | -2.15% |
| 3 Months | 1.075 | 1.40 | 0.8601 | 1.12 | 2,929,077 | -0.165 | -15.35% |
| 6 Months | 1.70 | 1.85 | 0.8601 | 1.34 | 4,748,341 | -0.79 | -46.47% |
| 1 Year | 0.85 | 2.99 | 0.3352 | 1.57 | 8,833,078 | 0.06 | 7.06% |
| 3 Years | 2.64 | 6.96 | 0.232963 | 1.45 | 3,575,131 | -1.73 | -65.53% |
| 5 Years | 6.35 | 6.96 | 0.232963 | 1.45 | 3,449,954 | -5.44 | -85.67% |
Aytu BioScience Description
| Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor. |
